VolitionRX VNRX reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:10 PM.
Here's what investors need to know about the announcement.
Earnings
VolitionRX missed estimated earnings by 7.14%, reporting an EPS of $-0.15 versus an estimate of $-0.14.
Revenue was up $35 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 11.69% increase in the share price the next day.
Here's a look at VolitionRX's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -0.15 | -0.15 | -0.15 | 0.02 |
EPS Actual | -0.13 | -0.14 | -0.14 | -0.14 |
Revenue Estimate | 220K | 90K | 110K | 10.03M |
Revenue Actual | 119K | 32K | 39K | 114K |
To track all earnings releases for VolitionRX visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.